Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference
November 06 2020 - 8:00AM
Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or
the “Company”), a clinical stage biotechnology company
discovering and developing novel antiviral therapeutics,
today announced that the Cocrystal management team, will present at
the H.C. Wainwright 6th Annual Israel Conference on Thursday,
November 12, 2020 at 12:00 PM EST.
In addition to the presentation, management will
also be available to participate in virtual one-on-one meetings
with qualified members of the investor community who are registered
to attend the conference.
A live video webcast of the presentation will be
available on the IR Calendar page of the Investors section of the
Company’s website (cocrystalpharma.com). The video webcast replay
will be made available two hours following the event.
About Cocrystal Pharma,
Inc.
Cocrystal Pharma, Inc. is a clinical stage
biotechnology company discovering and developing novel antiviral
therapeutics that target the replication process of influenza
viruses, SARS-CoV-2 virus, hepatitis C viruses, and norovirus.
Cocrystal employs unique, proprietary, structure-based technologies
and Nobel Prize winning expertise to create first- and
best-in-class antiviral drugs. For further information about
Cocrystal, please visit www.cocrystalpharma.com.
Investor and Media Contact:
JTC Team, LLC(833) 475-8247COCP@jtcir.com
###
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Sep 2023 to Sep 2024